Get started
Author

Georg Comes

Observed names: Comes Georg, G Comes, G. Comes
Observed institutions: Charles University, Masaryk University, Deutsche Klinik für Diagnostik, Merz (Germany), Heinrich Heine University Düsseldorf, University of Rostock, Palacký University Olomouc
ORCID: 0000-0002-4690-5425
Observed ORCID: 0000-0002-4690-5425
OpenAlex ID: A5023168014
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
2005 · R. Benecke, W. H. Jost, et al. · Neurology · 269
Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
2005 · P. Roggenkämper, W. H. Jost, et al. · Journal of Neural Transmission · 247
Efficacy and Safety of Botulinum Neurotoxin NT 201 in Poststroke Upper Limb Spasticity
2009 · Petr Kaňovský, Jaroslaw Slawek, et al. · Clinical Neuropharmacology · 119
Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity
2011 · P Kaňovský, J Slawek, et al. · Journal of Rehabilitation Medicine · 93
Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers
2004 · W. H. Jost, A. Kohl, et al. · Journal of Neural Transmission · 88
Neurophysiological Double-Blind Trial of a Botulinum Neurotoxin Type A Free of Complexing Proteins
2007 · Kai Wohlfarth, Christian Müller, et al. · Clinical Neuropharmacology · 72
Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
2021 · Jörg Wissel, Alexandre Camões-Barbosa, et al. · Toxins · 20
PDF
Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study
2022 · Cynthia Comella, Robert A. Hauser, et al. · Clinical Parkinsonism & Related Disorders · 17
PDF
Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
2023 · Alberto Albanese, Jörg Wissel, et al. · Toxins · 12
PDF
Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
2023 · Franco Molteni, Jörg Wissel, et al. · Toxins · 7
PDF
Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naïve subjects with spasticity
2021 · Julian Harriss, Nicolas Roche, et al. · Neurologia i Neurochirurgia Polska · 4
PDF
Early recognition of post-stroke spasticity: the I-REFER study
2026 · Klemens Fheodoroff, Benjamin Waeschle, et al. · Frontiers in Neurology · 2
PDF
Efficacy and Safety of IncobotulinumtoxinA in Older Patients with Upper Limb Spasticity: A Pooled Analysis
2025 · Michael C. Munin, Alexandre Camões-Barbosa, et al. · Geriatrics · 2
PDF
Protocol and Demographics of the RELY-CD Study: Assessing Long-Term Clinical Response to Botulinum Neurotoxin in Cervical Dystonia
2025 · Benjamin Waeschle, John-Ih Lee, et al. · Toxins · 1
PDF
Pain reduction in adults with cervical dystonia following a single injection of incobotulinumtoxina: A pooled analysis
2023 · Alberto Albanese, Jörg Wissel, et al. · Journal of the Neurological Sciences · 1
PDF
Safety of inhaled levodopa by treatment-related cough and throat irritation in Parkinson disease: a pooled post hoc analysis
2026 · Astrid Scheschonka, Margaret Ngure, et al. · Parkinsonism & Related Disorders
Efficacy of inhaled levodopa by age-based subgroups in Parkinson disease: post hoc analysis of pooled phase III trial data
2026 · Astrid Scheschonka, Margaret Ngure, et al. · Parkinsonism & Related Disorders
Efficacy and safety of inhaled levodopa with early and late treatment initiation in Parkinson disease: a pooled post hoc analysis
2026 · Astrid Scheschonka, Margaret Ngure, et al. · Parkinsonism & Related Disorders
Efficacy, safety, and tolerability of inhaled levodopa (CVT-301) across age, timing of motor fluctuations, and treatment initiation in Parkinson’s disease: Pooled analysis of three phase 3 trials
2026 · Joohi Jimenez-Shahed, Hubert H. Fernandez, et al. · Parkinsonism & Related Disorders
Real-world Evidence of Longevity of BoNT/A in Cervical Dystonia (RELY-CD) - Long-term Dose–effect Outcomes with Complex-free vs Complex-containing Botulinum Toxin Type A (P7-16.012)
2026 · Phillipp Albrecht, Benjamin Waeschle, et al. · Neurology
Evaluation of a Combination of Cystine, B Vitamins and Minerals, in the Management of Diffuse Hair Loss in Women: A Prospective, Open-Label Study
2026 · Birgit Bleßmann-Gurk, Welf Prager, et al. · Preprints.org
PDF
Primary Results of the Initial Validation of the SMD Decision Tree – I-REFER
2026 · Klemens Fheodoroff, Benjamin Waeschle, et al. · Toxicon
Improvement in Upper Limb Spasticity Patterns in the Elderly Following Treatment With IncobotulinumtoxinA: A Pooled Analysis
2026 · Michael C. Munin, Alexandre Camões-Barbosa, et al. · Toxicon
Moderate to Severe Upper Limb Spasticity Patterns in the Elderly Are Improved Following Treatment With IncobotulinumtoxinA: A Pooled Analysis
2026 · Michael C. Munin, Alexandre Camões-Barbosa, et al. · Toxicon
Real-world Evidence of Longevity of BoNT-A in Cervical Dystonia (RELY-CD)—Long-term Dose-Effect Outcomes With Complex-Free vs Complex-Containing Botulinum Toxin Type A
2026 · Benjamin Wäschle, John-Ih Lee, et al. · Toxicon
Works count: 55
Citation count: 954
H-index: 9
I10-index: 9
Year
Topic
Type